Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

NCT02661217 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1002

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction

Interventions

DRUG: LCZ696

Sponsor

Novartis Pharmaceuticals